People · Operator
Named in public records as an officer, director or promoter · active 2014–2025 · Biotechnology, Pharmaceuticals
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Aufbau Holdings Ltd | — | Biotechnology | Series A | $13.8M | $22.0M | 2023 |
| Mitochon Pharmaceuticals, Inc. | — | Pharmaceuticals | Pre-Seed | $1.3M | $20.1M | 2014 |
John Irwin at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside John Irwin on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| James Mitchell | 1 | 6 |
| John Geisler | 1 | 3 |
| Wayne Merkelson | 1 | 3 |
| H. Lawrence Remmel | 1 | 2 |
| Robert C. Hazlett | 1 | 1 |
| John T.G. Pena | 1 | 1 |
| Chairatch C. Phrompechrut | 1 | 1 |
| Peter Crooks | 1 | 1 |
| Robert Alonso | 1 | 1 |
| Bruce R. Thaw | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.